INSM - INSMED Inc
143.57
-6.310 -4.395%
Share volume: 2,267,930
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$149.88
-6.31
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 10-31-2024 | 02-20-2025 | 05-08-2025 | 08-07-2025 | 10-30-2025 | 02-19-2026 | |
| Assets | |||||||||
| Total Assets | 1.159 B | 1.810 B | 2.053 B | 2.025 B | 1.803 B | 2.480 B | 2.361 B | 2.265 B | |
| Current Assets | 758.722 M | 1.418 B | 1.650 B | 1.622 B | 1.403 B | 2.082 B | 1.932 B | 1.794 B | |
| Inventories | 82.957 M | 90.063 M | 98.470 M | 98.578 M | 100.713 M | 107.605 M | 120.965 M | 132.068 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 1.006 B | 878.796 M | 796.204 M | 572.441 M | 1.345 B | 919.602 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 595.729 M | 1.247 B | 461.451 M | 555.030 M | 403.247 M | 1.284 B | 334.764 M | 510.445 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 68.660 M | 72.777 M | 75.265 M | 80.052 M | 88.358 M | 89.995 M | 89.671 M | 102.942 M | |
| Other Assets | 331.713 M | 319.157 M | 327.862 M | 323.518 M | 311.685 M | 308.282 M | 339.258 M | 367.408 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.159 B | 1.810 B | 2.053 B | 2.025 B | 1.803 B | 2.480 B | 2.361 B | 2.265 B | |
| Total liabilities | 1.624 B | 1.771 B | 1.570 B | 1.740 B | 1.704 B | 1.230 B | 1.415 B | 1.526 B | |
| Total current liabilities | 420.860 M | 524.151 M | 259.188 M | 297.528 M | 239.233 M | 311.681 M | 417.214 M | 468.874 M | |
| Accounts Payable | 189.362 M | 290.844 M | 248.684 M | 285.209 M | 232.674 M | 305.019 M | 409.835 M | 456.060 M | |
| Other liabilities | 263.962 M | 300.324 M | 355.538 M | 338.942 M | 359.275 M | 379.933 M | 458.232 M | 515.744 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 939.081 M | 946.825 M | 954.831 M | 1.103 B | 1.105 B | 538.508 M | 539.719 M | 540.964 M | |
| Other liabilities | 263.962 M | 300.324 M | 355.538 M | 338.942 M | 359.275 M | 379.933 M | 458.232 M | 515.744 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -464.808 M | 38.818 M | 483.415 M | 285.379 M | 99.159 M | 1.250 B | 945.571 M | 738.976 M | |
| Common stock | 3.140 B | 3.945 B | 4.607 B | 4.648 B | 4.717 B | 6.186 B | 6.252 B | 6.374 B | |
| Retained earnings | -3.603 B | -3.904 B | -4.124 B | -4.360 B | -4.617 B | -4.938 B | -5.308 B | -5.637 B |